Oral and Poster Presentations at the 27th International Conference on Antiviral Research Home Spring Bank Pharmaceuticals Announces Oral and Poster Presentations at the 27th... International Conference on Antiviral Research 09 MAY 14 Spring Bank Pharmaceuticals Announces Oral and Poster Presentations at the 27th International Conference on Antiviral Research... of medical conditions, with a primary focus in antivirals, today announced three presentations on SB 9200, its lead drug candidate for the treatment of Hepatitis B (HBV) and Hepatitis C...

drug SB 9200 has demonstrated pan genotypic antiviral activity against all HCV genotypes in the hybrid fusion assay Home Spring Bank Pharmaceuticals HCV drug SB 9200 has... demonstrated pan genotypic antiviral activity against all HCV genotypes in the hybrid fusion assay 19 NOV 13 Spring Bank Pharmaceuticals HCV drug SB 9200 has demonstrated pan genotypic... antiviral activity against all HCV genotypes in the hybrid fusion assay Milford, November 11, 2013. Spring Bank Pharmaceuticals, Inc. of Milford, MA today announced that Dr. Graham...

dose (SAD) stage of the trial was designed to demonstrate the safety and antiviral activity of a single dose of SB 9200 at 100, 200, 400 and 800 mg once per day in treatment na ve HCV... to SB 9200. Evidence of antiviral activity was observed. The multiple ascending dose (MAD) stage of the trial is designed to show the safety, PK and antiviral activity of daily doses... infections and is based on Spring Bank s proprietary Small Molecule Nucleic Acid Hybrid (SMNH) technology platform. SB 9200 has a unique mechanism of antiviral action involving...

drugs to treat a number of medical conditions, with a primary focus in antivirals, today announced two presentations at the Nucleic Acid Summit 2014 held June 19-20, 2014 in San... Diego. The research presented continues 09 MAY 14 0 comments Spring Bank Pharmaceuticals Announces Oral and Poster Presentations at the 27th International Conference on Antiviral... a number of medical conditions, with a primary focus in antivirals, today announced three presentations on SB 9200, its lead drug candidate for the treatment of Hepatitis B (HBV...

on Nucleic acid-based scaffold: A novel approach to antiviral discovery . ACS Medicinal chemistry symposium on antiviral therapeutics , Boston, 2002. Iyer, R. P., Pandey, R.... 11. No. 16. (Pgs. 2057-60). Jin, Y.; Roland, A.; Zhou, W.; Fauchon, M.; Lyaku, J.; Iyer, R.P. Synthesis and antiviral evaluation of nucleic acid-based (NAB ) libraries..., B. Tennant, and J. D. Morrey. Nucleotide Analogs That Induce Cellular Production of Antimicrobial Proteins . International Conference of Antiviral Research, San Francisco, 2010. R...